CURRICULUM VITAE
John A. Charlson MD
John A. Charlson MD
Associate Professor
Department of Medicine
Division of Hematology and Oncology - Medicine
Department of Medicine
Division of Hematology and Oncology - Medicine
OFFICE ADDRESS: |
Clinical Cancer Center |
9200 W Wisconsin Ave |
Milwaukee, WI 53226 |
EDUCATION: |
09/1989 - 05/1993 B.A., Biology, Luther College, Decorah, IA |
09/1995 - 05/1999 M.D., University of Iowa College of Medicine, Iowa City, IA |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
07/1999 - 06/2002 Resident, Medicine, General Internal Medicine (GIM), Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI |
07/2005 - 06/2007 Fellow, Neoplastic Diseases, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI |
04/2013 Lean Healthcare Certificate Program, University of Michigan, Ann Arbor, MI |
01/2016 - 04/2016 Advanced Training Program in Healthcare Delivery Improvement, Intermountain Healthcare, Salt Lake City, UT |
FACULTY APPOINTMENTS: |
07/2002 - 06/2003 Chief Resident and Instructor, Medicine, Medical College of Wisconsin, Milwaukee, WI |
07/2003 - 06/2005 Assistant Professor and Hospitalist, Medicine, General Internal Medicine (GIM), Medical College of Wisconsin, Milwaukee, WI |
07/2007 - 06/2015 Assistant Professor, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI |
07/2015 - Present Associate Professor, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI |
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS: |
07/2002 - 06/2023 Resident Evaluation Committee, Medical College of Wisconsin, Milwaukee, WI |
01/2007 - 01/2008 Internal Review Committee, Pediatric Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI |
03/2008 - 07/2013 Internal Medicine Resident Curriculum Committee |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
01/2004 - 06/2005 Patient Safety Committee, Froedtert Hospital, Milwaukee, WI |
08/2009 - 06/2018 Cancer Center Process Improvement Committee |
09/2010 - Present Froedtert Cancer Committee, Froedtert Hospital, Milwaukee, WI |
01/2012 - Present Department of Medicine Quality Committee, Hem/Onc Division Representative, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI |
06/2012 - Present Pharmacy and Therapeutics, Oncology Subcommittee, Froedtert Cancer Center, Milwaukee, WI |
01/2013 - Present EPIC Stakeholders Committee, Froedtert Cancer Center, Milwaukee, WI |
07/2013 - 12/2017 Cancer Center Readmissions/Length of Stay Committee, Froedtert Cancer Center, Milwaukee, WI |
12/2013 - 06/2016 Department of Medicine Nominating Committee, Medicine, Medical College of Wisconsin, Milwaukee, WI |
04/2014 - 06/2016 Lab Utilization Committee, Froedtert Hospital/Medical College of Wisconsin, Milwaukee, WI |
07/2014 - 06/2016 Palliative Care Steering Committee, Medical College of Wisconsin, Milwaukee, WI |
03/2015 - 06/2018 Maintenance of Certification (MOC) Steering Committee, Medical College of Wisconsin, Milwaukee, WI |
09/2017 - Present Credentialing Committee, member, Medical College of Wisconsin, Milwaukee, WI |
07/2018 - 01/2023 Day Hospital Medical Director (0.05 FTE), Froedtert Hospital, Milwaukee, WI |
07/2019 - 01/2023 Cancer Center 24 Hour Clinic Medical Director, Froedtert Hospital, Milwaukee, WI |
RESEARCH ADMINISTRATIVE APPOINTMENTS: |
10/2012 - Present Data Safety Monitoring Committee, Froedtert Cancer Center, Milwaukee, WI |
02/2014 - Present Sarcoma DOT Research Co-chair, Froedtert Cancer Center, Milwaukee, WI |
10/2020 - Present Sarcoma LAPS Committee liaison, Froedtert Cancer Center, Milwaukee, WI |
HOSPITAL STAFF PRIVILEGES: |
07/2002 - Present Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Ave., Milwaukee, WI 53226 |
07/2002 - 06/2005 Zablocki VA Medical Center, 5000 W. National Ave., Milwaukee, WI 53295 |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
Americal Board of Internal Medicine- Internal Medicine | 09/2002 | 09/2012 |
American Board of Internal Medicine– Medical Oncology | 02/2007 | 02/2027 |
Licensure | Number | Issue Date | Expiration |
Wisconsin License | 42947-020 | 10/31/2003 | 10/31/2025 |
AWARDS AND HONORS: |
05/2004 Outstanding Performance Award, Primary Care Division, Clement Zablocki VA Medical Center, Milwaukee, WI |
09/2004 Top Ten Teaching Award, Medical Students, 2003-4, Medical College of Wisconsin, Department of Medicine |
09/2004 Top Ten Teaching Award, Residents, 2003-4, Medical College of Wisconsin, Department of Medicine |
10/2006 Donald J. Schuenke Cancer Fellowship |
12/2008 Top 20 Outpatient Physicians, Froedtert Hospital, Milwaukee, WI |
09/2009 - Present Best Doctors, 2009-2023, yearly |
01/2016 Vitality Award |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
10/2006 - Present American Society of Clinical Oncology |
09/2009 - Present Connective Tissue Oncology Society |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Editorial Board |
03/2019 - 03/2020 The Sarcoma Journal |
Journal Review |
PLOS One; Clinical Cancer Research; Journal of Clinical Oncology |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
09/2018 - 06/2020 Concept Review Committee, Sarcoma Alliance for Research through Collaboration (SARC) |
01/2021 - Present Medical Advisory Board, Rein In Sarcoma |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
National |
Lecture, Multi-disciplinary Management of Desmoid Tumors, Annual Musculoskeletal Oncology Symposium, Chicago, IL, 09/2019 |
Highlights of the Day Session: Sarcoma Highlights, SCO (American Society of Clinical Oncology) Annual Meeting, Virtual Meeting, 06/04/2021 |
“Sarcoma Chemotherapy Overview”, Rein In Sarcoma – Sarcoma Scholar Boot Camp, Virtual Meeting, Organizing site University of Minnesota, 09/08/2022 |
Sarcoma Tumor Board: Does Age Inflence Biology and Management? The Treatment of Sarcomas in Young Adults, American Society of Radiation Oncology Annual Meeting, San Antonio, TX, 10/24/2022 |
Regional |
Poster presentation – Hospitalists Providing Clinical Continuing Education for Inpatient Medical Nurses, Midwest SGIM regional meeting, Chicago, IL, 10/01/2004 |
Lecture – Transfusion Medicine, Seventeenth Annual Update in Primary Care, Medical College of Wisconsin, Egg Harbor, WI, 10/08/2004 |
Lecture – Management of Soft Tissue Sarcoma, Gundersen Clinic, La Crosse, WI, 08/13/2009 |
Lecture – Breast Cancer for Primary Care Physicians, 22nd Annual Update in Primary Care, Medical College of Wisconsin, Egg Harbor, WI, 10/09/2009 |
Lecture – Primary Care for Cancer Patients, American College of Physicians annual meeting, Wisconsin Dells, WI, 09/11/2010 |
Lecture – Sarcoma Update, Medical Oncology, Advances in Hematology and Oncology, Green Bay, WI, 10/2012 |
Lecture, Sarcoma Update, Agnesian Healthcare, Fond du Lac, WI, 03/2016 |
Lecture, Sarcoma Update, Hem Onc Grand Rounds, St Vincent Hospital, Green Bay, WI, 04/2016 |
Lecture, Sarcoma Treatment Update, 8th Annual Advances in Hematology and Oncology Fall Symposium, Green Bay, WI, 10/2019 |
Updates in Sarcoma Treatment, Bellin Oncology Grand Rounds, Bellin Hospital, Green Bay, WI (Virtual Meeting), 03/30/2022 |
Updates in Sarcoma Treatment, 11th Annual Advances in Hematology and Oncology Fall Symposium, Green Bay, WI, 10/29/2022 |
Local |
Lab Overutilization and Resident Education, MCW General Internal Medicine Division Meeting, Milwaukee, WI, 03/31/2004 |
42 y/o man with HIV and rash, Clinicopathologic Case Conference (CPC), Clement J. Zablocki VA Medical Center, Milwaukee, WI, 11/18/2004 |
Taking Care of Older Patients in Different Settings: A Physician Panel, Panel Discussion, Sponsored by MCW student chapters of ACP, AGS, 03/12/2007 |
Oncologic Emergencies, Emergency Medicine Grand Rounds, MCW Emergency Medicine Residency, 03/06/2008 |
Nutrition and Breast Cancer Risk, Women’s Health Event, St. Matthew’s Lutheran Church, Wauwatosa, WI, 01/31/2010 |
Long-Term Effects of Breast Cancer Treatment, Medicine Grand Rounds, MCW Department of Medicine, 02/26/2010 |
Lecture – Primary Care Followup after Breast Cancer Treatment, 41st Annual Winter Refresher Course for Family Medicine, Milwaukee, WI, 02/03/2011 |
Lecture – Long Term Effects of Cancer Treatment, 3rd, Annual Wisconsin Survivorship Forum, Milwaukee, WI, 06/2012 |
“Living with Sarcoma", survivor event (Assisted in planning, participated in physician Q&A panel), Crowne Plaza, Wauwatosa, WI, 04/2013 |
Sarcoma Program Overview, “Living with Sarcoma”, survivor event, Radisson Hotel, Wauwatosa, WI, 05/2014 |
Soft Tissue Sarcoma, Medical Oncology Perspective, MCW Department of Plastic Surgery Grand Rounds, Wauwatosa, WI, 10/2014 |
Chemotherapy for Sarcoma, Sarcoma Survivor Event, Milwaukee County Zoo, Milwaukee, WI, 04/2016 |
AYA Cancer Care, Medicine Grand Rounds, Medical College of Wisconsin, Milwaukee, WI, 04/2017 |
Using a Symptom Heuristics iPad App to Improve Symptom Self-Management in Adolescents and Young Adults with Cancer, CTSI Research Symposium Seminar, Medical College of Wisconsin, Milwaukee, WI, 11/19/2018 |
COMMITTEE SERVICE: |
Medical College of Wisconsin |
07/2002 - 06/2003 Resident Evaluation Committee, Medical College of Wisconsin |
03/2008 - Present Liaison between our division and medicine residency, coordinate resident lecture series and Medicine Grand Rounds speakers, Internal Medicine Resident Curriculum Committee, Medical College of Wisconsin |
12/2008 - Present Hematology/Oncology Fellowship Committee, Medical College of Wisconsin |
Planning Committee, 8th Biennial MCW Breast Cancer Symposium, Medical College of Wisconsin |
Hospital |
01/2004 - 06/2005 Patient Safety Committee, Froedtert Hospital |
01/2007 Internal Review Committee, Pediatric Hematology/Oncology Program |
08/2009 I serve as the primary physician representative on this quality improvement working group, implementing efforts to improve quality of care in the cancer center, Cancer Center Working Group Committee, Froedtert Hospital |
09/2010 - Present Froedtert Cancer Committee, Froedtert Hospital |
MCW TEACHING ACTIVITIES: |
Medical Student Education |
07/2002 - 06/2005 JMS Bedside Rounds, ward attending teaching |
01/2003 - 05/2003 M1 Interviewing Course |
03/2003 - 06/2008 Introduction to Clinical Exam (ICE) Course preceptor |
07/2004 - 06/2005 Lecturer, JMS Internal Medicine Core Lecture Series, Topic – Anemia |
08/2008 - 09/2018 Coordinator and preceptor, M4 Oncology Outpatient Clinic experience |
08/2008 - 09/2018 Course director and preceptor, M4 Oncology Inpatient Clinic elective rotation |
08/2008 - 09/2018 Course director and preceptor, M4 Oncology Consults Clinic elective rotation |
07/2010 - Present Preceptor, M4 Ambulatory Immersion rotation |
09/2010 - 09/2012 Pathology lecture – M2, Neoplasia Clinical Correlation |
09/2012 - 12/2014 Preceptor, M1 Clinical Apprenticeship Students Trevor Bluemel (2012-13)
and Anna Park (2013-14) |
06/2013 - 06/2014 Preceptor, Medical Student Summer Quality Improvement Project, student Benjamin
Morey. Breast clinic process improvement project |
01/2016 - Present Preceptor, M1/M2 Clinical Apprentice Rotation |
07/2019 - Present Faculty Advisor, medical student Oncology Interest Group |
Resident and Fellow Education |
07/2002 - 06/2003 Prepared monthly CPC conferences |
07/2002 - 06/2003 Led morning report, prepared Noon Conference lectures |
07/2003 - 06/2004 Resident continuity clinic preceptor |
09/2003 - 06/2005 Lecturer, Internal Medicine 101 course, topic – Neurologic Examination |
07/2004 - 06/2005 Director, Medicine Resident Procedures Rotation Coordinate procedural experiences for senior residents and implement curriculum dealing with issues related to bedside procedures |
07/2005 - 06/2007 Monthly lecture to residents on inpatient Oncology service |
07/2007 - Present Supervision and teaching as attending physician on Oncology consult and Oncology inpatient services |
07/2007 - 06/2017 Lecturer, hematology/oncology fellow core curriculum Sarcoma, Localized Breast Cancer |
08/2008 - 06/2017 Coordinator, hematology and oncology lecturers for Resident Academic Half Day |
01/24/2012 - 01/2014 Psychosomatic Medicine Resident Lecture, annual Psychiatric aspects of cancer
treatment |
05/30/2013 ER Resident Core Curriculum lecture, Oncologic Emergencies |
Continuing Medical Education |
01/2004 - 06/2005 Hospitalist Nursing Education Series A colleague and I provide CME for nursing staff using case-based discussions of inpatient medicine topics |
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Medical Students |
2018 - 2019 Trevor Argall, Research Advisor, Medical College of Wisconsin, GSTP1 Expression if Predictive of Sarcoma Response to Doxorubicin Based Chemotherapy. CTOS Annual Meeting 2019, Tokyo, Japan. Abstract 3256473, poster 150. |
Clinical/Research Fellows |
2020 - 2021 Ensi Voshtina, MCWAH Hem-Onc fellow, Research Advisor, Medical College of Wisconsin, Value and use of patient reported outcomes in sarcoma clinic through GetWell Loop app, ASCO Quality Care Symposium 2021. Abstract 347985. |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Fuller CK, Charlson JA, Dankle SK, Russell TJ. Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. J Am Acad Dermatol. 2010 Oct;63(4):e83-4. |
2. Walters MP, Baynes K, Carrera GF, King DM, Wang D, Charlson J, Zambrano E. Adamantinoma with plasmacytoid features: expanding the spectrum of a diagnostically challenging entity. Ann Diagn Pathol. 2011 Oct;15(5):347-54. |
3. Yao X, Hosenpud J, Chitambar CR, Charlson J, Cheng YC. A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. J Cancer. 2012;3:145-51. PMCID: PMC3319980 |
4. Bedi M, King DM, Shivakoti M, Wang T, Zambrano EV, Charlson J, Hackbarth D, Neilson J, Whitfield R, Wang D. Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy. Radiat Oncol. 2013 Mar 14;8:60. PMCID: PMC3621722 |
5. Bedi M, King DM, Charlson J, Whitfield R, Hackbarth DA, Zambrano EV, Wang D. Multimodality management of metastatic patients with soft tissue sarcomas may prolong survival. Am J Clin Oncol. 2014 Jun;37(3):272-7. |
6. Bedi M, King DM, Whitfield R, Hackbarth DA, Neilson JC, Charlson JA, Wang D. The effect of smoking and major vein resection on post-therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb-salvage surgery. Am J Clin Oncol. 2015 Apr;38(2):184-8. |
7. Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM. Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. Springerplus. 2015;4(1):54. PMCID: PMC4320689 |
8. Bedi M, King DM, Saeed H, Tutton S, Charlson, JA, Hackbarth DA, Neilson JC. Localized Management of Soft Tissue Sarcoma Metastasis: A Review of a Multidisciplinary Approach. Can Res Frontiers. 2015;1(2):138. doi: 10.17980/2015.162 |
9. Neuner JM, Kamaraju S, Charlson JA, Wozniak EM, Smith EC, Biggers A, Smallwood AJ, Laud PW, Pezzin LE. The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees. J Natl Cancer Inst. 2015 Aug;107(8). PMCID: PMC4580559 |
10. Bedi M, King DM, Hackbarth DA, Charlson JA, Baynes K, Neilson JC. Biopsies in the Community Lead to Postoperative Complications in Soft Tissue Sarcomas. Orthopedics. 2015 Sep;38(9):e753-9. |
11. Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM. Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. Springerplus. 2015;4:531. PMCID: PMC4577495 |
12. Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma. Eur J Surg Oncol. 2015 Oct;41(10):1386-92. |
13. Klooster B, Rajeev R, Chrabaszcz S, Charlson J, Miura J, Bedi M, Gamblin TC, Johnston F, Turaga KK. Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)? J Surg Oncol. 2016 Jun;113(7):823-7. |
14. D'Angelo SP, Araujo DM, Abdul Razak AR, Agulnik M, Attia S, Blay JY, Carrasco Garcia I, Charlson JA, Choy E, Demetri GD, Druta M, Forcade E, Ganjoo KN, Glod J, Keedy VL, Le Cesne A, Liebner DA, Moreno V, Pollack SM, Schuetze SM, Schwartz GK, Strauss SJ, Tap WD, Thistlethwaite F, Valverde Morales CM, Wagner MJ, Wilky BA, McAlpine C, Hudson L, Navenot JM, Wang T, Bai J, Rafail S, Wang R, Sun A, Fernandes L, Van Winkle E, Elefant E, Lunt C, Norry E, Williams D, Biswas S, Van Tine BA. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. Lancet. 2024 Apr 13;403(10435):1460-1471. PMCID: PMC11419333 |
15. Rajeev R, Patel M, Jayakrishnan TT, Johnston FM, Bedi M, Charlson J, Turaga KK. Retroperitoneal solitary fibrous tumor: surgery as first line therapy. Clin Sarcoma Res. 2015;5:19. PMCID: PMC4551387 |
16. Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma. Eur J Surg Oncol 2015;41:1386. PMID:26251340. |
17. Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim K, Charlson JC, Wisinski KB, Tevaarwerk AJ. Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result. J Community Support Oncol. 2015 May;13(5):195-201. PMCID: PMC4511377 |
18. Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM. Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy. J Clin Oncol. 2016 Dec 20;34(36):4398-4404. PMCID: PMC5455308 |
19. Kashtan MA, Jayakrishnan TT, Rajeev R, Charlson JC, Johnston F, Clark Gamblin T, Turaga KK. Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma. Int J Clin Oncol. 2016 Jun;21(3):602-8. |
20. Saeed H, King DM, Johnstone CA, Charlson JA, Hackbarth DA, Neilson JC, Bedi M. Preoperative Radiation Therapy Followed by Reexcision May Improve Local Control and Progression-Free Survival in Unplanned Excisions of Soft Tissue Sarcomas of the Extremity and Chest-Wall. Int J Surg Oncol. 2016;2016:5963167. PMCID: PMC5075633 |
21. Charlson J, Smith EC, Smallwood AJ, Laud PW, Neuner JM. Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors. J Natl Compr Canc Netw. 2016 Jul;14(7):875-80. |
22. Charlson JA, McGinley EL, Nattinger AB, Neuner JM, Pezzin LE. Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D. J Natl Compr Canc Netw. 2017 Dec;15(12):1509-1517. |
23. Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin TC. Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. Surgery. 2018 Feb;163(2):318-323. |
24. Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA. Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. J Cancer Surviv. 2018 Apr;12(2):268-275. |
25. Charlson J. Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy. Curr Treat Options Oncol. 2018 Oct 25;19(12):65. |
26. Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN. Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. J Surg Res. 2019 Jan;233:154-162. |
27. Zarnecki KG, Kristianto J, Charlson J, Wilson B, Blank RD, Shaker JL. Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1. Osteoporos Int. 2019 Aug;30(8):1699-1703. |
28. Gannon NP, King DM, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Votanopoulos K, Krasnick B, Fields RC, Cardona K, Bedi M. The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. J Surg Oncol. 2019 Sep;120(3):325-331. |
29. Patel S, von Mehren M, Reed DR, Kaiser P, Charlson J, Ryan CW, Rushing D, Livingston M, Singh A, Seth R, Forscher C, D'Amato G, Chawla SP, McCarthy S, Wang G, Parekh T, Knoblauch R, Hensley ML, Maki RG, Demetri GD. Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. Cancer. 2019 Aug 01;125(15):2610-2620. PMCID: PMC6771856 |
30. Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. J Surg Res. 2020 Jan;245:577-586. |
31. Bedi M, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Cardona K, King DM. Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity? Clin Orthop Relat Res. 2020 Mar;478(3):550-559. PMCID: PMC7145071 |
32. Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborative. Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. J Surg Oncol. 2020 Jun;121(7):1140-1147. |
33. Macpherson CF, Stegenga K, Erickson JM, Linder LA, Newman AR, Elswick RK, Charlson J, Thomas S, Ameringer S. Adolescents and Young Adults with Cancer Using a Symptom Heuristics App: Provider Perceptions and Actions. J Adolesc Young Adult Oncol. 2020 Oct;9(5):579-585. PMCID: PMC7578178 |
34. Monga V, Skubitz KM, Maliske S, Mott SL, Dietz H, Hirbe AC, Van Tine BA, Oppelt P, Okuno S, Robinson S, O'Connor M, Seetharam M, Attia S, Charlson J, Agulnik M, Milhem M. A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas. Cancers (Basel). 2020 Jul 11;12(7). PMCID: PMC7408640 |
35. Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery. 2020 Oct;168(4):760-767. |
36. Schulte B, Mohindra N, Milhem M, Attia S, Robinson S, Monga V, Hirbe AC, Oppelt P, Charlson J, Helenowski I, Abbinanti S, Cehic R, Okuno S, Van Tine BA, Agulnik M. Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas. Br J Cancer. 2021 Aug;125(4):528-533. PMCID: PMC8368095 |
37. Ibrahim EH, Frank L, Baruah D, Arpinar VE, Nencka AS, Koch KM, Muftuler LT, Unal O, Stojanovska J, Rubenstein JC, Brown SA, Charlson J, Gore EM, Bergom C. Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging. Int J Biomed Imaging. 2021;2021:8851958. PMCID: PMC8147553 |
38. Ellison C, King DM, Neilson JC, Wooldridge A, Charlson JA, Hackbarth DA, Johnstone C, Bedi M. Preoperative Radiation Performed at a Nonsarcoma Center May Lead to Increased Wound Complications Following Resection in Patients With Soft Tissue Sarcomas. Am J Clin Oncol. 2021 Dec 01;44(12):619-623. |
39. Bedi M, Singh R, Charlson JA, Kelly T, Johnstone C, Wooldridge A, Hackbarth DA, Moore N, Neilson JC, King DM. Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma. Adv Radiat Oncol. 2022;7(3):100850. PMCID: PMC9133395 |
40. Drom C, Schenheit K, Matzke M, Obeidat AZ, Molinaro J, Charlson J, Knight JM. Abrupt onset of severe parkinsonism in a patient with metastatic gastrointestinal stromal tumor receiving treatment with avapritinib: A case report. Brain Behav Immun Health. 2023 Feb;27:100570. PMCID: PMC9791578 |
41. Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. N Engl J Med. 2023 Mar 09;388(10):898-912. PMCID: PMC11225596 |
42. Wilcox T, Kleinertz A, Seadler BD, Joyce LD, Charlson J, Linsky PL. Transmediastinal primary pulmonary liposarcoma: Case report and review of management strategies. Rare Tumors. 2024;16:20363613241274230. PMCID: PMC11320392 |
Books, Chapters, and Reviews |
1. Kochar's Handbood of Clinical Medicine for Students, 4th ed., 2009; contributing author for hematology and oncology chapters. |
2. Sarcomas: Evidence-based Diagnosis and Management, 1st ed., 2020; senior author for Synovial Sarcoma chapter. |
Editorials, Letters To Editor, Other |
1. Charlson JA, ASCO Co-chair. MSTS, ASTRO, ASCO: The treatment of metastatic carcinoma and myeloma of the femur: Clinical practice guideline. Available at http://msts.org/view/download.php/education/mbd-cpg-amended. 2020. |
Non-Refereed Journal Publications/Original Papers |
1. Charlson J, Heinrich T, McCarron RM. How often should women be screened for breast cancer? Current Psychiatry. 2010 Oct;9(10):20-22. |
Abstracts |
1. Charlson JA, Hedin, T, Sparapani R, Guo C, Nattinger A. Early discontinuation of tamoxifen and aromatase inhibitors (AIs) by postmenopausal women with early-stage breast cancer. ASCO Annual Meeting 2010, abstract 524, poster discussion session. |
2. Yao X, Hosenpud JR, Chitambar CR, Charlson JA, Cheng Y. Phase II study of combined docetaxel, epirubicin, and cyclophosphamide as a neoadjuvant chemotherapy regimen in patients with locally advanced breast cancer in a single institution. ASCO Annual Meeting 2010, abstract e11040. |
3. Bedi M, King D, Hackbarth D, Charlson J, Whitfield R, Wang D. Prognostic variables for post-metastasis survival in patients with soft tissue sarcoma of the extremity and trunk. CTOS Annual Meeting 2011, poster 49. |
4. Bedi M, King D, Zambrano E, Shivakoti M, Baynes K, Mautz A, DuBois M, Charlson J, Hackbarth D, Wang D. Estimation of prognostic variables for survival in patients with primary localized soft tissue sarcoma of extremity and trunk treated with neoadjuvant radiation of chemoradiation. CTOS Annual Meeting 2011, poster 132. |
5. Ridolfi K, Zhang C, Onitilo A, Ledesma W, Andreason M, Engel J, Kim K, Wisinski KB, Tevaarwerk A, Charlson J. Obesity at diagnosis and breast cancer (BC) recurrence risk based on the 21-gene assay recurrence score (RS). J Clin Oncol (Meeting Abstracts) May 2012, vol 30, no. 15, abstract 555. |
6. Andreason M, Zhang C, Onitilo A, Charlson J, Ledesma W, Ridolfi K, Kim K, Wisinski K, Champeny T, Engel J, Millholland R, Dean J, Tevaarwerk A. Rural versus urban differences among patients (pts) with hormone-receptor positive (HR+) breast cancer (BC) and a 21-gene assay recurrence score (RS). ASCO Annual Meeting 2012, abstract 6063. |
7. Ledesma WM, Onitilo A, Zhang C, Kim K, Andreason M, Charlson J, Ridolfi K, Engel J, Wisinski K, Millholland R, Dean J, Tevaarwerk A. Impact of exogenous female hormone use (EHU) on breast cancer (BC) recurrence as assessed by the 21-gene assay (Oncotype DX). ASCO Annual Meeting 2012, abstract 563. |
8. Charlson JA, Smith E, Laud P, Smallwood A, Neuner J. Baseline bone mineral density testing among breast cancer patients prescribed aromatase inhibitors (AIs). J Clin Oncol 2013, vol 31 suppl; abstract 6642. |
9. Biggers A, Neuner J, Smith E, Pezzin L, Laud P, Charlson J, Smallwood A. Medicare Part D low-income subsidy and disparities in breast cancer treatment. J Clin Oncol 2014. 32 supplement; abstract 6534. |
10. Charlson J, Trabucco S, Ali S, Stephens P. Frequency of Cell-Cycle Gene Alterations in Bone Sarcomas. CTOS Annual Meeting 2017, abstract 2788006. |
11. Bedi M, Mostafa M, Charlson J, Suster S, Johnstone C, Clarke C. Tumor Infilitrating Lymphocytes May Predict for Distant Metastasis in Soft Tissue Sarcomas. CTOS Annual Meeting 2018, Rome, Italy. Abstract 3042484. |
12. Charlson J, Argall T, Szabo A. GSTP1 Expression if Predictive of Sarcoma Response to Doxorubicin Based Chemotherapy. CTOS Annual Meeting 2019, Tokyo, Japan. Abstract 3256473. |
13. Voshtina E, Charlson JA. Value and use of patient reported outcomes in sarcoma clinic through GetWell Loop app. Journal of Clinical Oncology. 2021;39(28_suppl):179. |